Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $670 | In Stock | |
5 mg | $1,470 | In Stock | |
10 mg | $1,980 | In Stock | |
25 mg | $2,930 | In Stock | |
50 mg | $3,960 | In Stock |
Description | Dalzanemdor (SAGE-718) is an NMDA receptor-positive modulator of metabolism that can be used to study Huntington's chorea, Alzheimer's disease, and cognitive dysfunction. |
In vivo | SAGE-718 (Dalzanemdor) (5), a potent and high intrinsic activity NMDAR PAM with an optimized pharmacokinetic profile for oral dosing. Compound 5 has completed phase 1 single ascending dose and multiple ascending dose clinical trials and is currently undergoing phase 2 clinical trials for the treatment of cognitive impairment in Huntington's disease.[2] |
Alias | SAGE-718 |
Molecular Weight | 456.62 |
Formula | C27H43F3O2 |
Cas No. | 1629853-48-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||
Solubility Information | chloroform: 5.68 mg/mL (12.44 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
chloroform
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.